Strategies for ensuring diversity, inclusion, and meaningful participation in clinical trials : proceedings of a workshop / Karen M. Anderson and Steve Olson, rapporteurs ; Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities, Board on Population Health and Public Health Practice, Health and Medicine Division, The National Academies of Sciences, Engineering, Medicine.

Format:

Book

Conference/Event

Author/Creator:

Anderson, Karen M., author.

National Academies of Sciences, Engineering, Medicine. Health and Medicine Division. Board on Population Health and Public Health Practice. Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities, issuing body.

Contributor:

Anderson, Karen M., contributor.

Olsen, Steven, contributor.

National Academies of Sciences, Engineering, and Medicine (U.S.). Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities, issuing body.

Conference Name:

Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials (Workshop) (2015 : Washington, D.C.), author.

Language:

English

Subjects (All):

Clinical trials--United States--Congresses.

Clinical trials.

Minorities--United States.

Minorities.

Women--United States.

Women.

Physical Description:

1 online resource (85 pages) : illustrations (some color)

Edition:

1st ed.

Place of Publication:

Washington, DC : The National Academies Press, [2016]

Summary:

Even as the U.S. population becomes steadily more diverse, minorities and women remain underrepresented in clinical trials to develop new drugs and medical devices. Although progress in increasing minority participation in clinical trials has occurred, participation rates do not fully represent the overall population of minorities in the United States. This underrepresentation threatens the health of both these populations and the general population, since greater minority representation could reveal factors that affect health in all populations. Federal legislation has sought to increase the representation of minorities and women in clinical trials, but legislation by itself has not been sufficient to overcome the many barriers to greater participation. Only much broader changes will bring about the meaningful participation of all population groups in the clinical research needed to improve health. To examine the barriers to participation in clinical trials and ways of overcoming those barriers, the National Academies of Sciences, Engineering, and Medicine held a workshop in April 2015. This publication summarizes the presentations and discussions from the workshop.

Contents:

Introduction and highlights of the workshop

Historical perspectives and context

Scientific issues : clinically meaningful inclusion

Recruitment and retention issues : patient, provider, institutional, and system barriers

Potential best practices and policy options.

Notes:

Includes bibliographical references.

Description based on online resource; title from PDF title page (ebrary, viewed October 6, 2016).

ISBN:

0-309-44360-1

0-309-44358-X